Skip to content

Clinical trials

Observational COVID-19 trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Observational Country / region: South Africa Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20207
20214
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
COVID-19 Prevention Network1
Farzanah Laher1
Foundation for Innovative New Diagnostics, Switzerland1
HIV Vaccine Trials Network1
Kirby Institute1
Klaus Reither1
Medical University of Graz1
National Institute for Communicable Diseases, South Africa1
PENTA Foundation1
Pharm-Olam, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1913
Acquired Immunodeficiency Syndrome2
Alagille Syndrome1
Cardiovascular Diseases1
Communicable Diseases1
Coronavirus Infections1
Influenza, Human1
Post-Acute COVID-19 Syndrome1
Tuberculosis1
Tuberculosis, Pulmonary1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.